Cardiosolutions, Inc. is a development stage company focused on a novel percutaneous alternative to open heart surgery to solve the problem of mitral regurgitation.
Currently, we are developing a pioneering technology, the Percu-Pro System™, designed to deliver an implant that will provide a sealing surface for the leaflets of the mitral valve, thereby significantly reducing or eliminating mitral regurgitation (MR).
Our goal is to provide a new therapeutic alternative for a wide range of patients of all ages who suffer from moderate to severe mitral regurgitation, including a portion of those who are currently in congestive heart failure. Our percutaneous procedure has the potential to substantially reduce procedure time, expedite patient recovery and provide a less costly alternative to current treatment options.